RCKT
Rocket Pharmaceuticals Inc
Halal Rating :
Last Price
$10.30
Last updated:
Market Cap
-
7D Change
-4.01%
1 Year Change
-63.28%
Company Overview
Industries
Exchange
Next Earnings Date
Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing gene therapies for rare and devastating diseases. The company uses lentiviral vector (LVV) and adeno-associated virus (AAV) gene therapy platforms to address serious diseases. Their pipeline includes treatments for Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, and Danon Disease.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Rocket Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.